Post by
SchiffKnowsBest on Dec 18, 2017 12:55pm
It's Go Time!!!!
Fresh off the presses.......
Vancouver, British Columbia, December 18, 2017 – Med BioGene Inc. (“MBI” or the
“Company”) (TSXV: MBI) is pleased to announce that it has received the approval of the TSX
Venture Exchange to the consolidation of its issued and outstanding common shares on the basisof one new common share for every ten common shares currently issued and outstanding. The Company’s shares will commence trading on the TSX Venture Exchange on a consolidated basis at the opening of the market on Tuesday, December 19, 2017. On a post-consolidationbasis, there are approximately 8,757,835 common shares issued and outstanding. The Company’s name and trading symbol will remain the same. Management believes that the consolidation is in the best interest of the Company and will allow the Company greater possibilities with respect to needed future financing.
Comment by
smpt88 on Dec 18, 2017 2:41pm
better buy now cheap $0.015, tmr $0.15, next year $1.50 and so on and on.